Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Each session lasts about 4050 minutes and is administered by licensed medical professionals in a calm, spa-like environment
The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort
Researchers conducted an exploratory analysis of women who delivered a baby in the University of Florida Health perinatal catchment area and used a GLP-1 2 years or less before delivery
3.7 Summary of metabolic outcomes: building foundation for fertility treatment Across available trials, GLP-1RAs consistently improve metabolic drivers that are clinically relevant to fertility planning in PCOS
